Skip to main content
SpringerLink
Log in

Quality of Life During and After Treatment of Hodgkin’s Disease

  • Conference paper
New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 117))

Abstract

During recent decades prognosis and survival in Hodgkin’s disease have improved strikingly. For all patients, the rate of cure is approximately 75% and for the majority, with limited disease (stage I-IIIA), it is nearly 90% (Zittoun et al. 1985). Improving the quality of life for the majority of patients has also been a basic aim in recent years (Hœrni et al. 1983; Eghbali and Hœrni-Simon 1984).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aaronson NK, Beckmann J (eds) (1987) The quality of life of cancer patients. Raven, New York

    Google Scholar 

  • Anonymous (1987) Who should treat Hodgkin“s disease and where? Lancet I: 605

    Google Scholar 

  • Behrendt H, Van Bunningen BNFM, Van Leeuwen EF (1987) Treatment of Hodgkin“s disease in children with or without radiotherapy. Cancer 59: 1870–1873

    Article  PubMed  CAS  Google Scholar 

  • Bookman MA, Longo DL (1986) Concomitant illness in patients treated for Hodgkin“s disease. Cancer Treat Rev 13: 77–111

    Article  PubMed  CAS  Google Scholar 

  • Brämswig JH, Heiermann E, Heimes U, Schlegel W, Nieschlag E, Schellong G (1987) Testicular function in boys treated for Hodgkin“s disease. Prospective evaluation in 68 boys of the DAL-HD-78 and DAL-HD-82 therapy study. Third International Conference on Malignant Lymphoma, Lugano (abstr p 25 )

    Google Scholar 

  • Chauvergne J, Hcerni B, Hcerni-Simon G, Durand M, Lagarde C (1973) Chimiothérapie de la maladie de Hodgkin associant procarbazine, vinblastine, cyclophosphamide et méthylprednisolone. Analyse d“une série de 124 cures. Z Krebsforsch 80: 179–188

    Article  CAS  Google Scholar 

  • Combes PF, Desclaux B, Malissard L, Pons A (1977) Poids du diagnostic de maladie de Hodgkin sur la qualité de la vie des sujets qui en sont guéris. Bull Cancer (Paris) 64: 395–408

    CAS  Google Scholar 

  • Cosset JM, Henry-Amar M, Ozanne F, Le Bourgeois JP (1984) Les péricardites radiques. Etudes des cas observés dans une série de 160 maladies de Hodgkin irradiées en mantelet à l“Institut Gustave-Roussy, de 1976 à 1980. J Eur Radiothérapie 5: 297–308

    Google Scholar 

  • Eghbali H, Hcerni-Simon G (1984) Qualité de la vie et maladie de Hodgkin. In: Schraub S, Brugère J, Hcerni B (eds) Qualité de la vie et cancers. Progrès en cancérologie, 4. Doin, Paris, pp 283–290

    Google Scholar 

  • Ferme C, Teillet F, d“Agay MF, Gisselbrecht C, Marty M, Boiron M (1984) Combined modality in Hodgkin“s disease. Comparison of six versus three courses of MOPP with clinical and surgical restaging. Cancer 54: 2324–2329

    Google Scholar 

  • Fobair P, Hoppe RT, Bloom J, Cox R, Varghese A, Spiegel D (1986) Psychosocial problems among survivors of Hodgkin“s disease. J Clin Oncol 4: 805–814

    PubMed  CAS  Google Scholar 

  • Gallez-Marchal D, Fayolle M, Henry-Amar M, Le Bourgeois JP, Rougier P, Cosset JM (1984) Radiation injuries of the gastrointestinal tract in Hodgkin“s disease: the role of exploratory laparotomy and fractionation. A study of 19 cases observed in a series of 134 patients treated at the Institut Gustave-Roussy from 1972 to 1982. Radiother Oncol 2: 93–99

    Article  PubMed  CAS  Google Scholar 

  • Guinee VF, Guido JJ, Pfalzgraf KA et al. (1985) The incidence of herpes zoster in patients with Hodgkin“s disease. An analysis of prognostic factors. Cancer 56: 642–648

    Article  PubMed  CAS  Google Scholar 

  • Henry-Amar M (1988) Quantitative risk of second cancer in patients in first complete remis-sion from early stages of Hodgkin“s disease. NCI Monogr 6: 65–72

    PubMed  Google Scholar 

  • Hcerni B (ed) (1982) L“information des personnes malades. SIMEP, Lyon-Villeurbanne

    Google Scholar 

  • Hcerni B for Groupe Pierre-et-Marie-Curie (1985) Enquête psychosociale chez 28 adolescents traités pour une maladie de Hodgkin. Psychol Med 17: 1975–1976

    Google Scholar 

  • Hcerni B, Hcerni-Simon G, Eghbali H, Richaud P (1983) Qualité de vie pendant et après association radio-chimiothérapique pour maladie de Hodgkin. Appréciation de 60 malades. Bull Cancer (Paris) 70: 284–288

    Google Scholar 

  • Hcerni B, Zittoun R, Rojouan J et al. (1986a) Information des malades traités pour une maladie de Hodgkin. Liaisons avec la qualité de vie. Bull Cancer (Paris) 73: 305–310

    Google Scholar 

  • Hcerni B, Zittoun R, Rojouan J et al. (1986 b) Retentissement psychosocial du traitement de la maladie de Hodgkin. Appréciation par questionnaire auprès de 150 malades. Bull Cancer (Paris) 73: 620–626

    Google Scholar 

  • Hcerni B, Orgerie MB, Eghbali H et al. (1988) Nouvelle association d“epirubicine, bléomycine, vinblastine et prednisone (EBVPII) avant radiothérapie dans les stades localisés de maladie de Hodgkin. Essai de phase II chez 50 malades. Bull Cancer (Paris) 75: 789–794

    Google Scholar 

  • Hcerni-Simon G, Zittoun R (1985) Coût thérapeutique et qualité de vie pendant et après le traitement d“une maladie de Hodgkin. In: Hcerni-Simon G, Gisselbrecht C (eds) Maladie de Hodgkin. Progrès en hématologie, 7. Doin, Paris, pp 179–191

    Google Scholar 

  • Jacobs C, Ross RD, Walker IM, Stockdale FE (1983) Behavior of cancer patients: a randomized study of the effects of education and peer support groups. Am J Clin Oncol 6: 347–353

    Article  PubMed  CAS  Google Scholar 

  • Lagarde P, Eghbali H, Bonichon F et al. (1988) Brief chemotherapy associated with extended field radiotherapy in Hodgkin“s disease. Long-term results in a series of 102 patients with clinical stages I-IIIA. Eur J Cancer Clin Oncol 24: 1191–1198

    Article  PubMed  CAS  Google Scholar 

  • Pohjola-Sintonen S, Tötterman KJ, Salmo M, Siltanen P (1987) Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin“s disease. Cancer 60: 31–37

    Article  PubMed  CAS  Google Scholar 

  • Santoro A, Bonfante V, Bonadonna G et al. (1981) Therapeutic and toxicologic effects of MOPP-ABVD combined with radiotherapy in Hodgkin“s disease. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer III. Grune and Stratton, New York, pp 85–91

    Google Scholar 

  • Strull WM, Lo B, Charles G (1984) Do patients want to participate in medical decision making. JAMA 252: 2990–2994

    Article  PubMed  CAS  Google Scholar 

  • Torti FM, Bristow MM, Lum BL et al. (1986) Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy. Cancer Res 46: 3722–3727

    PubMed  CAS  Google Scholar 

  • Wasserman AL, Thompson EI, Wilimas JA, Fairclough DL (1987) The psychological status of survivors of childhood/adolescent Hodgkin“s disease. Am J Dis Child 141: 626–631

    PubMed  CAS  Google Scholar 

  • Zittoun R (1985) Indications thérapeutiques et processus décisionnel dans la maladie de Hodgkin. In: Hcerni-Simon G, Gisselbrecht C (eds) Maladie de Hodgkin. Progrès en Hématologie, 7. Doin, Paris, pp 193–215

    Google Scholar 

  • Zittoun R, Audebert A, Hcerni B et al. (1985) Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin“s disease. J Clin Oncol 3: 207–214

    PubMed  CAS  Google Scholar 

  • Zittoun R, Eghbali H, Audebert A et al. (1987) Association d“épirubicine, bleomycine, vinblastine et prednisone (EBVP) avant radiothérapie dans les stades localisés de la maladie de Hodgkin. Essai de phase II. Bull Cancer (Paris) 74: 151–157

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fondation Bergonié, 180, Rue de Saint-Genés, 33076, Bordeaux Cedex, France

    B. Hœrni & H. Eghbali

Authors
  1. B. Hœrni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Eghbali
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. I. Medizinische Universitätsklinik Köln, Joseph-Stelzmann-Straße 9, 5000, Köln 41, Germany

    Volker Diehl , Michael Pfreundschuh  & Markus Loeffler ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Hœrni, B., Eghbali, H. (1989). Quality of Life During and After Treatment of Hodgkin’s Disease. In: Diehl, V., Pfreundschuh, M., Loeffler, M. (eds) New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease. Recent Results in Cancer Research, vol 117. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83781-4_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83781-4_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-83783-8

  • Online ISBN: 978-3-642-83781-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation